Improved detection of myocardial perfusion reversibility by rest-nitroglycerin Tc-99m-MIBI: Comparison with Tl-201 reinjection

Journal of Nuclear Cardiology

Volumn 6, Issue 5, 1999, Pages 480-486

  Batista, Juan F ^a   Pereztol, Osvaldo ^b   Valdés, José A ^b   Sánchez, Elvia ^b   Stusser, Rodolfo ^b   Rochela, Luis M ^b   López, Desiree ^b   Garcia, Ernest V ^b  

^a Center for Clinical Research   (Cuba)

^b NONE

Author keywords

Myocardial reversibility; Nitroglycerin; Tc 99m MIBI; Tl 201 reinjection

Indexed keywords

GLYCERYL TRINITRATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOISOTOPE; THALLIUM 201;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EXERCISE; FEMALE; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; REST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBLINGUAL DRUG ADMINISTRATION;

EID: 0032747686     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(99)90019-3     Document Type: Article

References (41)

1. Schelbert H, Phelps ME, Hoffman E, Huang SC, Kuhl DE. Regional myocardial blood flow, metabolism, and function assessed noninvasively with positron emission tomography. Am J Cardiol 1980;80:1269-77.
2. Marshall RC, Tillisch JH, Phelps ME, Huang SC, Carson R, Henze E, et al. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation 1983:67:766-78.
3. Tillisch JH, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Schelbert H. Reversibility of cardiac wall-motion abnormalities predicted by positron emission tomography. N Engl J Med 1986;314:884-8.
4. Brunken R, Schwaiger M, Grover-McKay M, Phelps ME, Tillisch J, Schelbert HR. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol 1987;10:557-67.
5. Brunken RC, Kottou S, Nienaber CA, Schwaiger M, Ratib OM, Phelps ME, et al. PET detection of viable tissue in myocardial segments with persistent defects at Tl-201 SPECT. Radiology 1989;65:65-73.
6. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with F-18 fluorodeoxiglucose. Circulation 1991;83:26-37.
7. Petretta M, Cuocolo A, Bonaduce D, Nicolai E, Cardei S, Berardino S, et al. Incremental prognostic value of thallium reinjection after stress-redistribution imaging in patients with previous myocardial infarction and left ventricular dysfunction. J Nucl Med 1997;38:195-200.
8. Iskandrian AS, Hakki AH, Kane SA, Goel IP, Mundth ED, Segal BL, et al. Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary artery bypass grafting. Am J Cardiol 1983;51:1312-6.
9. Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stresss-redistribution imaging. N Engl J Med 1990;323:141-6.
10. Beanland RS, Dawood F, Wen WH, McLauhhlin PR, Butany J, D'Amati G, et al. Are the kinetics technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation 1990;82:1802-14.
11. Freeman I, Grunwald AM, Hoory S, Bodenheimer MM. Effect of coronary occlusion and myocardial viability on myocardial activity of technetium-99m-sestamibi. J Nucl Med 1991;32:292-8.
12. 99mTc-MIBI SPET: a comparative study in patients with coronary artery disease. Eur J Nucl Med 1992;19:334-42.
13. Marzullo P, Sambuceti G, Parodi O. The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability. J Nucl Med 1992;33:1925-30.
14. Altehoefer C, vom Dahl J, Biederman M, Vebis R, Beilin I, Sheehan F, et al. Significance of defect severity in technetium-99m-MIBI SPET at rest to assess myocardial viability: comparison with fluorine-18-FDG-PET. J Nucl Med 1994;35:569-74.
15. Dondi M, Tartagni F, Fallani F, Fanti S, Marengo M, DiTommaso I, et al. A comparison of rest sestamibi and rest-redistribution thallium single photon emission tomography: possible implications for myocardial viability detection in infarcted patients. Eur J Nucl Med 1993;20: 26-31.
16. Brown BG, Bolson EL, Petersen RB, Pierce CD, Dodge HT. The mechanism of nitroglycerin action: stenosis vasodilation as a major component of the drug response. Circulation 1981;64:1089-97.
17. Cohn PF, Maddox D, Holman BL, Markis JE, Adams DF, See JR. Effect of sublingually administered nitroglycerin on regional myocardial blood flow in patients with coronary artery disease. Am J Cardiol 1977;39:672-8.
18. Cohen MV, Sonnenblick EH, Kirk ES. Comparative effects of nitroglycerin and isosorbide dinitrate on coronary collateral vessels and ischemic myocardium in dogs. Am J Cardiol 1976;37:244-9.
19. He ZX, Darcourt J, Guignier A, Ferrari E, Bussiere F, Baudouy M, et al. Nitrates improve detection of ischemic but viable myocardium by thallium-201 reinjection SPET. J Nucl Med 1993;34:1472-7.
20. He ZX, Medrano R, Hays JT, Mahmarian JJ, Verani MS. Nitroglycerin-augmented Tl-201 reinjection anhanced detection of reversible myocardial hypoperfusion: A randomized, double-blind, parallel, placebo-controlled trial. Circulation 1997;95:1799-805.
21. Bisi G, Sciagrá R, Santoro GM, Rossi V, Fazzini PF. Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularization recovery. J Nucl Med 1995;36:1994-2000.
22. Bisi G, Sciagrá R, Santoro G, Zerauschek F, Fazzini PF. Sublingual isosorbide dinitrate to improve technetium-99m-teboroxime perfusion defect reversibility. J Nucl Med 1994;35;1274-8.
23. Sinusas AJ, Bergin JD, Edwards NC, Watson DD, Ruiz M, Makuch RW, et al. Redistribution of 99mTc-sestamibi and 201Tl in the presence of a severe coronary artery stenosis. Circulation 1994;89:2332-41.
24. 18F (fluorodeoxyglucose). Circulation 1994;89:578-87.
25. Udelson JE. Can technetium 99m-labeled sestamibi track myocardial viability? J Nucl Cardiol 1994;1:571-5.
26. 99mTc-sestamibi. Circulation 1994;89:2552-61.
27. Rocco TP, Dilsizian V, McKusick KA, Fischman AJ, Boucher CA, Strauss HW. Comparison of thallium redistribution with rest "reinjection" imaging for the detection of viable myocardium. Am J Cardiol 1990;66:158-63.
28. Sciagrá R, Bisi G, Santoro GM, Zerauschek F, Sestini S, Pedenovi PF, et al. Comparison of baseline-nitrate technetium-99m setamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery. J Am Coll Cardiol 1997;30:384-91.
29. Marcassa C, Galli M, Cuocolo A, Scappellato F, Maurea S, Salvatore M. Rest-redistribution thallium-201 and rest technetium-99m-sestamibi SPECT in patients with stable coronary artery disease and ventricular dysfunction. J Nucl Med 1997;38:419-24.
30. Marzullo P, Parodi O, Reisenhofer B, Sambuceti G, Picano E, Distante A, et al. Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol 1993;71:166-72.
31. Naruse H, Daher E, Sinusas A, Jain D, Natale D, Mattera J, et al. Quantitative comparison of planar and spect normal data files of thallium-201, technetium-99m-sestamibi, technetium-99m-tetrofosmin and technetium-99m-furifosmin. J Nucl Med 1996;37:1783-8.
32. Maurea S, Cuocolo A, Soricelli A, Castelli L, Nappi A, Squame F, et al. Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med 1995;36:1945-52.
33. Huang GH, Zhao HY, Shan YF, Zhen J, Li J-B, Yan Y, et al. Comparison between nitrate Tc-99m-MIBI and Tl-201 reinjection tomography in detecting viable myocardium [abstract]. Eur J Nucl Med 1996;23:1162.
34. Bisi G, Sciagrá R, Santoro GM, Fazzini PF. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994;24:1282-9.
35. Marzullo P, Sambuceti G, Parodi O, Gimelli A, Picano E, Giorgetti A, et al. Regional concordance and discordance between rest thallium 201 and sestamibi imaging for assessing tissue viability: comparison with postrevascularization functional recovery. J Nucl Cardiol 1995;2:309-16.
36. Medrano R, Lowry RW, Young JB, Weilbaecher DG, Michael LH, Afridi I, et al. Assessment of myocardial viability with technetium-99m sestamibi in patients undergoing cardiac transplantation: a scintigraphic pathologic study. Circulation 1996;94:1010-7.
37. Galli M, Marcassa C, Imparato A, Campini R, Orrego PS, Giannuzzi PF. Effects of nitroglycerin by technetium-99m sestamibi tomoscintigraphy on resting regional myocardial hypoperfusion in stable patients with healed myocardial infarction. Am J Cardiol 1994;74:843-8.
38. Bax JJ, Cornel JH, Visser FC, Fioretti PM, van Lingen A, Huitink LM, et al. Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography. J Am Coll Cardiol 1997;30:377-83.
39. Burt RW, Perkins OW, Oppenhein BE, Schauwecker DS, Stein L, Wellman HN, et al. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability. J Nucl Med 1995;36:176-9.
40. Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. J Nucl Med 1992;33:505-11.
41. Pereztol O, Valdés JA, Batista JF, López D, Sánchez E, Pérez B. Comparación de las imágenes de 99mTc-MIBI reposo y 99mTc-MIBI NTG SPET: posibles implicaciones en la detección de la viabilidad miocárdica. Rev Esp Med Nuclear 1996;4:221-7.